Arteris, Inc. (NASDAQ:AIP) Shares Bought by MetLife Investment Management LLC

MetLife Investment Management LLC raised its holdings in Arteris, Inc. (NASDAQ:AIP) by 129.1% during the 3rd quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 16,951 shares of the company’s stock after purchasing an additional 9,551 shares during the period. MetLife Investment Management LLC’s holdings in Arteris were worth $131,000 at the end of the most recent quarter.

A number of other institutional investors and hedge funds have also made changes to their positions in the business. Essex Investment Management Co. LLC acquired a new position in Arteris during the third quarter worth $2,504,000. Bank of New York Mellon Corp purchased a new stake in shares of Arteris during the second quarter worth about $580,000. CloudAlpha Capital Management Limited Hong Kong acquired a new position in shares of Arteris during the 2nd quarter worth about $554,000. Rhumbline Advisers raised its position in shares of Arteris by 2,182.8% during the 2nd quarter. Rhumbline Advisers now owns 31,822 shares of the company’s stock worth $239,000 after purchasing an additional 30,428 shares during the last quarter. Finally, Dynamic Technology Lab Private Ltd purchased a new position in Arteris in the 3rd quarter valued at about $226,000. 64.36% of the stock is currently owned by hedge funds and other institutional investors.

Wall Street Analyst Weigh In

Separately, Rosenblatt Securities reiterated a “buy” rating and set a $15.00 price objective on shares of Arteris in a research note on Wednesday, November 6th.

Arteris Price Performance

Arteris stock opened at $8.81 on Tuesday. The company has a fifty day simple moving average of $7.78 and a 200-day simple moving average of $7.78. The firm has a market capitalization of $353.99 million, a price-to-earnings ratio of -9.18 and a beta of 1.25. The company has a quick ratio of 1.16, a current ratio of 1.16 and a debt-to-equity ratio of 0.30. Arteris, Inc. has a 52-week low of $4.83 and a 52-week high of $9.54.

Insider Buying and Selling

In related news, VP Paul L. Alpern sold 3,615 shares of the company’s stock in a transaction dated Friday, October 4th. The shares were sold at an average price of $7.13, for a total value of $25,774.95. Following the completion of the sale, the vice president now owns 68,084 shares of the company’s stock, valued at approximately $485,438.92. This represents a 5.04 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which can be accessed through this link. Also, CFO Nicholas B. Hawkins sold 5,000 shares of Arteris stock in a transaction dated Wednesday, December 4th. The stock was sold at an average price of $8.76, for a total transaction of $43,800.00. Following the transaction, the chief financial officer now directly owns 184,977 shares in the company, valued at $1,620,398.52. This trade represents a 2.63 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last three months, insiders have sold 103,321 shares of company stock worth $801,119. 33.70% of the stock is owned by insiders.

About Arteris

Arteris, Inc provides semiconductor interconnect intellectual property (IP) and System-on-Chip (Soc) Integration Automation software solutions (SIA) in the Americas, the Asia Pacific, Europe, and the Middle East. The company develops, licenses, and supports the on-chip interconnect fabric technology used in Soc designs and Network-on-Chip (NoC) interconnect IP.